Our patient investment philosophy
A Patient View
"Time is the friend of the wonderful company, the enemy of the mediocre."- Warren Buffett
- Compels us to wait for the perfect pitch - differentiated companies with strong cash flows, low debt, high quality products or services, significant barriers to entry and low reinvestment requirements.
- Allows us to take a long-term view and look past short-term noise with a 3-5 year time horizon in mind.
A Focused Approach
"Invest within your circle of competence." - Warren Buffett- Augments our conviction, especially during crunch time when it matters most.
- Leads us to isolate key issues of importance to a company in the midst of market noise.
- Results in our portfolio concentration in a limited number of names and industries.
A Team of Independent Thinkers
"If you buy the same stocks as everyone else, you get the same results."- Sir John Templeton
- Encourages us to buy out of favor, misunderstood and ignored stocks.
- Leads us to perform our own original, proprietary research.
- Persuades us to be benchmark agnostic with very different industry weightings.
We believe ethical business practices make good investment sense.
We do not invest in corporations whose primary source of revenue is derived from:
- the production or sale of tobacco products or
- the manufacture of handguns.
Additionally, we consider a company’s environmental record which includes reviewing research from outside vendors that provide such services, and we encourage portfolio companies to have proactive diversity practices.
For more information, read The Responsibility Factor.
Investor Class: 11/06/1986
Institutional Class: 12/30/2011
Investor Class: ARGFX
Institutional Class: ARAIX
$2.0 billion as of 3/31/2013
[video] Chairman, CEO & CIO John W. Rogers, Jr. takes a deeper dive on some of his favorite stock picks
USA Today highlights Ariel Fund and Ariel Appreciation Fund
[video] John W. Rogers, Jr. and Impact Players host Robert Wolf discuss expectations for 2013, why Warren Buffett's direction makes sense, and more
Ariel Fund Performance as of May 31, 2013
| Inception date: November 6, 1986 | Annualized | |||||||
| One Month | Three Months | Year To Date | One Year | Three Years | Five Years | Ten Years | Since Inception | |
|---|---|---|---|---|---|---|---|---|
| Ariel Fund | 1.48% | 6.27% | 17.77% | 38.07% | 14.80% | 7.90% | 7.89% | 11.26% |
| Russell 2500™ Value Index | 2.31% | 7.20% | 16.28% | 33.31% | 16.17% | 7.52% | 10.47% | 11.48% |
| Russell 2000® Value Index | 2.99% | 7.17% | 14.85% | 31.31% | 13.97% | 6.51% | 9.53% | 10.73% |
| S&P 500® Index | 2.34% | 8.22% | 15.37% | 27.28% | 16.87% | 5.43% | 7.58% | 9.90% |
Ariel Fund Performance as of March 31, 2013
| Inception date: November 6, 1986 | Annualized | |||||||
| One Month | Three Months | Year To Date | One Year | Three Years | Five Years | Ten Years | Since Inception | |
|---|---|---|---|---|---|---|---|---|
| Ariel Fund | 4.46% | 15.76% | 15.76% | 21.57% | 12.59% | 8.18% | 9.06% | 11.26% |
| Russell 2500™ Value Index | 4.49% | 13.35% | 13.35% | 21.17% | 14.16% | 8.81% | 12.14% | 11.45% |
| Russell 2000® Value Index | 4.16% | 11.63% | 11.63% | 18.09% | 12.12% | 7.29% | 11.29% | 10.69% |
| S&P 500® Index | 3.75% | 10.61% | 10.61% | 13.96% | 12.67% | 5.81% | 8.53% | 9.79% |
> Compare Performance for all our Funds
> View Historical Quarter-by-Quarter Performance
Investing in small cap and mid-cap stocks is more risky and more volatile than investing in large cap stocks. Ariel Fund often invests a significant portion of its assets in companies within the financial services and consumer discretionary sectors and its performance may suffer if these sectors underperform the overall stock market. Performance data quoted represents past performance. Past performance does not guarantee future results. All performance assumes the reinvestment of dividends and capital gains. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
One of the fund’s benchmarks has been changed from the Russell 2500 Index to the Russell 2000 Value Index as the Adviser believes the new index is more indicative of the market capitalization and style profile of the fund. The Russell 2500™ Value Index measures the performance of the small to mid-cap value segment of the U.S. equity universe. It includes those Russell 2500 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 2000® Value Index measures the performance of the small-cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values. Russell® is a trademark of Russell Investment Group, which is the source and owner of the Russell Indexes’ trademarks, service marks and copyrights. The S&P 500® Index is the most widely accepted barometer of the market. It includes 500 blue chip, large cap stocks, which together represent about 75% of the total U.S. equities market.
Average Annual Total Return does not reflect a maximum 4.75% sales load charged prior to 07/15/94.
Investors should consider carefully the investment objectives, risks, and charges and expenses before investing. For a current summary prospectus or full prospectus which contains this and other information about the funds offered by Ariel Investment Trust, call us at 800-292-7435 or click here. Please read the summary prospectus or full prospectus carefully before investing. Distributed by Ariel Distributors, LLC, a wholly-owned subsidiary of Ariel Investments, LLC.
Schedule of Holdings as of March 31, 2013
| Shares | Security Description | CUSIP | Ticker | Current Value ($) | % of Net Assets |
|
|---|---|---|---|---|---|---|
| 3,937,704 | KKR & Co. L.P. | 48248M102 | KKR | 76,076,441 | 3.9 | |
| 3,301,101 | Gannett Co., Inc. | 364730101 | GCI | 72,195,079 | 3.7 | |
| 5,296,961 | Interpublic Group of Cos., Inc. | 460690100 | IPG | 69,019,402 | 3.5 | |
| 7,074,366 | Janus Capital Group Inc. | 47102X105 | JNS | 66,499,040 | 3.4 | |
| 1,014,413 | Life Technologies Corp. | 53217V109 | LIFE | 65,561,512 | 3.3 | |
| 1,479,001 | Charles River Laboratories Intl Inc. | 159864107 | CRL | 65,475,374 | 3.3 | |
| 1,889,108 | Lazard Ltd | G54050102 | LAZ | 64,475,256 | 3.3 | |
| 1,931,711 | Hospira, Inc. | 441060100 | HSP | 63,418,072 | 3.2 | |
| 739,893 | Dun & Bradstreet Corp. | 26483E100 | DNB | 61,892,049 | 3.1 | |
| 1,893,401 | International Speedway Corp. | 460335201 | ISCA | 61,876,345 | 3.1 | |
| 621,314 | Jones Lang LaSalle Inc. | 48020Q107 | JLL | 61,764,825 | 3.1 | |
| 2,333,498 | CBRE Group, Inc. | 12504L109 | CBG | 58,920,825 | 3.0 | |
| 2,285,963 | First American Financial Corp. | 31847R102 | FAF | 58,452,074 | 3.0 | |
| 495,476 | Mohawk Industries, Inc. | 608190104 | MHK | 56,048,245 | 2.8 | |
| 2,141,509 | Newell Rubbermaid Inc. | 651229106 | NWL | 55,893,385 | 2.8 | |
| 845,026 | Bristow Group Inc. | 110394103 | BRS | 55,721,014 | 2.8 | |
| 1,206,428 | Fair Isaac Corp. | 303250104 | FICO | 55,121,695 | 2.8 | |
| 780,313 | Anixter Intl Inc. | 035290105 | AXE | 54,559,485 | 2.8 | |
| 3,300,763 | International Game Technology | 459902102 | IGT | 54,462,590 | 2.8 | |
| 3,426,300 | Western Union Co. | 959802109 | WU | 51,531,552 | 2.6 | |
| 1,322,813 | Meredith Corp. | 589433101 | MDP | 50,610,825 | 2.6 | |
| 598,913 | Snap-on Inc. | 833034101 | SNA | 49,530,105 | 2.5 | |
| 363,306 | Bio-Rad Laboratories, Inc. | 090572207 | BIO | 45,776,556 | 2.3 | |
| 1,127,403 | Contango Oil & Gas Co. | 21075N204 | MCF | 45,197,586 | 2.3 | |
| 1,469,627 | Simpson Manufacturing Co., Inc. | 829073105 | SSD | 44,985,283 | 2.3 | |
| 99,778 | Washington Post Co. | 939640108 | WPO | 44,600,766 | 2.3 | |
| 1,277,580 | Royal Caribbean Cruises Ltd. | V7780T103 | RCL | 42,441,208 | 2.2 | |
| 41,114,222 | Fixed Income Clearing Corporation | 85748R009 | 41,114,222 | 2.1 | ||
| 1,192,239 | Brady Corp. | 104674106 | BRC | 39,975,774 | 2.0 | |
| 683,644 | Madison Square Garden Co. | 55826P100 | MSG | 39,377,894 | 2.0 | |
| 655,970 | City National Corp. | 178566105 | CYN | 38,643,193 | 2.0 | |
| 1,176,490 | DeVry Inc. | 251893103 | DV | 37,353,558 | 1.9 | |
| 644,741 | IDEX Corp. | 45167R104 | IEX | 34,442,064 | 1.8 | |
| 1,758,506 | Interface, Inc. | 458665304 | TILE | 33,798,485 | 1.7 | |
| 865,650 | Sotheby's | 835898107 | BID | 32,383,967 | 1.6 | |
| 457,966 | Littelfuse, Inc. | 537008104 | LFUS | 31,072,993 | 1.6 | |
| 2,180,672 | Symmetry Medical Inc. | 871546206 | SMA | 24,968,694 | 1.3 | |
| 215,785 | J.M. Smucker Co. | 832696405 | SJM | 21,397,241 | 1.1 | |
| 217,241 | Zimmer Holdings, Inc. | 98956P102 | ZMH | 16,340,868 | 0.8 | |
| 293,638 | Nordstrom, Inc. | 655664100 | JWN | 16,217,627 | 0.8 | |
| 214,095 | McCormick & Co., Inc. | 579780206 | MKC | 15,746,687 | 0.8 | |
| Cash, Other Assets and Liabilities | -5,771,136 | -0.3 | ||||
| Grand Total | $1,969,168,720 | 100.0% | ||||
The four-part investment process drives us to take a long-term view, focusing on what matters most through independent thought and research.
The Idea: We read extensively, monitor computer screens, meet with industry experts, and stay abreast of former holdings.
The Science: We seek to purchase companies that trade at a 40% discount to the PMV we have calculated, sell for 13x or less forward cash earnings estimates, or both.
The Art: We surround companies to paint a long-term picture and identify what others are missing. The chief tool is our extensive independent verification network — the many experts we know well. We use strategic questioning of company management and outside experts to identify the key issues affecting an industry or company.
The Decision: We generally purchase only a few companies each year so we weigh our options carefully. Typically, key information is captured in a research report. Our research team vets the idea in a vigorous discussion and each senior research team member weighs in. After this step, the lead portfolio manager makes the final purchase decision.
Sector Weightings (%) as of March 31, 2013
| Ariel Fund | Russell 2500 Value | Russell 2000 Value | S&P 500 | |
|---|---|---|---|---|
| Consumer Discretionary | 35.27 | 12.38 | 12.61 | 13.61 |
| Financial Services | 30.68 | 33.24 | 37.86 | 17.19 |
| Health Care | 14.56 | 6.48 | 4.67 | 12.37 |
| Producer Durables | 8.34 | 13.55 | 12.86 | 10.57 |
| Materials and Processing | 4.07 | 7.78 | 7.09 | 3.78 |
| Technology | 2.82 | 8.07 | 9.95 | 15.65 |
| Energy | 2.34 | 6.62 | 6.02 | 10.93 |
| Consumer Staples | 1.92 | 2.16 | 2.21 | 9.56 |
| Utilities | 0.00 | 9.71 | 6.75 | 6.33 |
> View Historical Sector Diversification
Represents percentage of total equity holdings in the portfolio
Portfolio Characteristics as of March 31, 2013
| Market Capitalization | Ariel Fund | Russell 2500 Value | Russell 2000 Value | S&P 500 | |
|---|---|---|---|---|---|
| Market Capitalization | (In billions) | ||||
| Large Capitalization | 64.31 & Above | 0.0 | 0.0 | 0.0 | 48.1 |
| Medium/Large Capitalization | 18.65 -- 64.31 | 0.0 | 0.0 | 0.0 | 31.4 |
| Medium Capitalization | 6.39 -- 18.65 | 20.7 | 9.4 | 0.0 | 18.1 |
| Medium/Small Capitalization | 2.39 -- 6.39 | 44.8 | 50.6 | 12.5 | 2.4 |
| Small Capitalization | 2.39 & Below | 34.5 | 40.0 | 87.5 | 0.0 |
| Dollar-Weighted Average (BIL)* | $3.50 | $2.46 | $1.04 | $58.72 | |
| Valuation Metrics | |||||
| Forward Price/Earnings | 14.7 | 14.8 | 14.9 | 14.0 | |
| Trailing Price/Earnings | 19.5 | 20.3 | 23.3 | 17.0 | |
| Discount to Private Market Value | -14.8 | n/a | n/a | n/a | |
| Fundamentals | |||||
| 5 Yr. Estimated Earnings Growth ** | 11.3 | 10.2 | 10.1 | 10.8 | |
| Interest Coverage Ratio | 4.5 | 4.3 | 4.2 | 7.2 | |
| Portfolio Construction | |||||
| Number of Holdings | 40 | 1,776 | 1,403 | 500 | |
| Turnover | 41.1 | n/a | n/a | n/a | |
> View Historical Portfolio Characteristics
Market Capitalization data, Valuation Metrics, Fundamentals and Number of Holdings are obtained from BNY Mellon. Portfolio Turnover is generated internally through Fiserv APL.
*Market Capitalization is a dollar-weighted average natural log. Using the natural log of each stock’s market capitalization reduces the weight given to the largest companies in a simple averaging process.
**This measure is not a forecast of the fund’s performance.
One of the fund’s benchmarks has been changed from the Russell 2500 Index to the Russell 2000 Value Index as the Adviser believes the new index is more indicative of the market capitalization and style profile of the fund. The Russell 2500™ Value Index measures the performance of the small to mid-cap value segment of the U.S. equity universe. It includes those Russell 2500 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 2000® Value Index measures the performance of the small-cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values. Russell® is a trademark of Russell Investment Group, which is the source and owner of the Russell Indexes’ trademarks, service marks and copyrights. The S&P 500® Index is the most widely accepted barometer of the market. It includes 500 blue chip, large cap stocks, which together represent about 75% of the total U.S. equities market.


